Shuttle Pharmaceuticals Holdings (SHPH) Profit After Tax (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Profit After Tax of -$2.2 million for Q1 2026, up 29.5% year-over-year from -$1.7 million in Q1 2025, and up 17.68% quarter-over-quarter from -$2.6 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Profit After Tax (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Profit After Tax history runs 6 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 29.5% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$10.8 million (down 3.39% YoY), while the FY2025 annual figure was -$11.7 million, down 28.18% from the prior year.
- Profit After Tax for Q1 2026 stood at -$2.2 million, up from -$2.6 million in the prior quarter.
- The five-year high for Profit After Tax was -$597275.0 in Q2 2022, with the low at -$3.8 million in Q3 2024.
- The 5-year median for Profit After Tax is -$1.8 million (2023), against an average of -$1.9 million.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax plunged 360.19% in 2022, then soared 37.97% in 2025.
- Shuttle Pharmaceuticals Holdings' Profit After Tax stood at -$750909.0 in 2022, then plunged by 118.47% to -$1.6 million in 2023, then advanced by 2.56% to -$1.6 million in 2024, then plunged by 63.59% to -$2.6 million in 2025, then rose by 17.68% to -$2.2 million in 2026.
- Business Quant data shows SHPH's Profit After Tax at -$2.2 million in Q1 2026, -$2.6 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | -2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.15 Mn |
| Dec 31, 2025 | -2.61 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | -3.71 Mn |
| Mar 31, 2025 | -3.05 Mn |
| Dec 31, 2024 | -1.60 Mn |
| Sep 30, 2024 | -3.78 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.64 Mn |
| Sep 30, 2023 | -1.79 Mn |
| Jun 30, 2023 | -2.18 Mn |
| Mar 31, 2023 | -975,097.00 |
| Dec 31, 2022 | -750,909.00 |
| Sep 30, 2022 | -998,425.00 |
| Jun 30, 2022 | -597,275.00 |
| Mar 31, 2022 | -681,839.00 |
| Dec 31, 2021 | -459,048.00 |
| Sep 30, 2021 | -216,961.00 |